TrialBioMed research international2018

Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial.

Mariana S Xavier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.